Richard Seist to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Richard Seist has written about TOR Serine-Threonine Kinases.
Connection Strength
0.108
-
Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Sci Rep. 2020 03 06; 10(1):4211.
Score: 0.108
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.